Merck is in advanced talks to buy cancer drugmaker Harpoon Therapeutics

, January 8, 2024
Pharma

Merck & Co. has agreed to acquire cancer drugmaker Harpoon Therapeutics Inc. for $680 million as it seeks to solidify its leadership position in the profitable oncology space.

Wegovy, Ozempic not linked to increase in suicidal thoughts, study finds

, January 8, 2024
Pharma

A large study found no evidence that taking Novo Nordisk's Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported.

Psychedelics are going mainstream. Investing in them hasn't.

, January 8, 2024
Pharma

Drugs like LSD have shown potential for treating psychiatric disorders. Wall Street and big pharma aren't convinced.

Merck looks to join the obesity drug frenzy

, January 5, 2024
Pharma

Merck & Co. is seeking new obesity-fighting drugs called GLP-1s, joining a host of companies angling for a slice of the exploding market.

FDA issues first approval for mass drug imports to states from Canada

, January 5, 2024
Pharma

The agency authorized Florida to purchase medicines directly from wholesalers in Canada, where prices are far cheaper. Pharmaceutical companies oppose the plan.

FDA looking into reports of hair loss, suicidal thoughts in people using popular drugs for diabetes and weight loss

, January 4, 2024
Pharma

The FDA is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking medications like Ozempic, Mounjaro and Wegovy.

Pages